ID

20232

Beschrijving

The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one.

Trefwoorden

Versies (2)
  1. 15-02-17 15-02-17 -
  2. 20-02-17 20-02-17 -
Geüploaded op

15 februari 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Visit 1A Events PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

Engels

Visit 1A Events PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulieren  
Events
Beschrijving

Events

Alias
UMLS CUI-1
C0877248
1. Has the patient experienced any of the following since randomization:
Beschrijving

Patient experience

Datatype

text

Dizziness or Lightheadedness
Beschrijving

Dizziness or Lightheadedness

Datatype

boolean

Fainting
Beschrijving

Fainting

Datatype

boolean

Alias
UMLS CUI [1]
C0039070
Headache during first week of study drug administration
Beschrijving

Headache

Datatype

boolean

If headache occurred please indicate how it was treated (indicate all that apply):
Beschrijving

If headache

Datatype

integer

2. Have any Outcome Events or Serious Adverse Events been experienced? (See instructions on facing page)
Beschrijving

Outcome Events or Serious Adverse Events

Datatype

boolean

if "Yes" please indicate all that apply
Beschrijving

If Yes

Datatype

integer

Please complete the respective forms
Beschrijving

Please complete the respective forms

4. Signature of Investigator or Sub-Investigator
Beschrijving

By signing and dating this page, I declare that I have reviewed for accuracy all the case report form pages for this patient visit; the information contained on these pages accurately reflects the medical record including the results of tests and evaluations performed on the specified dates.

Datatype

text

Date of Signature (dd mon yy)
Beschrijving

Date of Signature

Datatype

date

Terug naar het begin van de pagina

Similar models

Visit 1A Events PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Events
C0877248 (UMLS CUI-1)
Patient experience
Item
1. Has the patient experienced any of the following since randomization:
text
Dizziness or Lightheadedness
Item
Dizziness or Lightheadedness
boolean
Fainting
Item
Fainting
boolean
C0039070 (UMLS CUI [1])
Headache
Item
Headache during first week of study drug administration
boolean
Item
If headache occurred please indicate how it was treated (indicate all that apply):
integer
If headache
Code List
If headache occurred please indicate how it was treated (indicate all that apply):
CL Item
Analgestic (1)
CL Item
Down titration of study medication A (2)
CL Item
No treatment (3)
Outcome Events or Serious Adverse Events
Item
2. Have any Outcome Events or Serious Adverse Events been experienced? (See instructions on facing page)
boolean
Item
if "Yes" please indicate all that apply
integer
If Yes
Code List
if "Yes" please indicate all that apply
CL Item
Stroke (1)
CL Item
Myocardial Infarction (2)
CL Item
Death (3)
CL Item
New or worsening congestive heart failure (CHF) (4)
CL Item
Other designated vascular event (5)
CL Item
Hemorrhagic Event (6)
CL Item
Thrombotic Thrombocytopenia purpura (7)
CL Item
Neutropenia (8)
CL Item
Newly diagnosed diabetes (9)
Item Group
Please complete the respective forms
Signature of Investigator or Sub-Investigator
Item
4. Signature of Investigator or Sub-Investigator
text
Date of Signature
Item
Date of Signature (dd mon yy)
date
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial